[The expressions and the roles of SDF-1/CXCR-4 and SDF-1/CXCR-4 in human endometriosis].
article
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
High expression of SDF-1 and CXCR-4 in endometriosis promotes endometrial stromal cell mitosis and proliferation, indicating their significant roles in the disease's pathogenesis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The high expressions of SDF-1 and CXCR-4 in endometriosis as well as SDF-1 through its specific receptor CXCR-4 promoted the mitosis and proliferation of endometrial stromal cells, suggesting that SDF-1 and CXCR-4 played important roles in the pathogenesis of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (4)
- Efficacy of niclosamide on the intra‐abdominal inflammatory environment in endometriosis 2021
- Copaiba Oil Resin Exerts an Additive Effect to Babassu Oil on Behavioral Changes in Human Endometriotic Cell Cultures 2022
- Particularități histopatologice și evaluarea imunohistochimică a procesului de invazivitate în endometrioza extragenitală 2025
- Copaiba Oilresin Exerts an Additive Effect to the Babassu Oil on Behavioral Changes in Human Endometriotic Cell Cultures 2022
Cited by (4)
- Particularități histopatologice și evaluarea imunohistochimică a procesului de invazivitate în endometrioza extragenitală 2025
- Copaiba Oilresin Exerts an Additive Effect to the Babassu Oil on Behavioral Changes in Human Endometriotic Cell Cultures 2022
- Copaiba Oil Resin Exerts an Additive Effect to Babassu Oil on Behavioral Changes in Human Endometriotic Cell Cultures 2022
- Efficacy of niclosamide on the intra‐abdominal inflammatory environment in endometriosis 2021
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:19:43.094626+00:00
License: CC0
· commercial use OK